Addressing Inflation A Prime Concern For Global Pharma

Pharmaceutical companies across the globe must brace themselves for higher and consistent inflationary pressures which were not assumed to be there previously.

Antibiotics Shortage Challenge - A Growing Concern For Europe

European Union is taking into account all the required regulatory options and ensuring a faster rate of production while at the same time cutting shortages.

A Sizeable Increase In Healthcare Deals Anticipated In 2023

The entire value of M&A deals in pharma and life sciences industry may hit $225 billion to $275 billion in 2023, according to PricewaterhouseCoopers prediction.

UK - Perfect Destination For Conducting ATMP Clinical Trials

UK which remained a global leader in clinical research for 2022 continues to show its dominance in the ATMP clinical trials as well with a continuous growth.

Microbiome Industry Explores Hong Kong As APAC Region Centre

Due to intellectual property protection and cutting-edge technology, Hong Kong can be looked as a potential centre across APAC for the microbiome industry.

FDA Wraps Up The REMS Standards For Prescription Medicines

For some medicines, FDA may find that a more formalized plan is appropriate, in which scenario a Risk Evaluation and Mitigation Strategy will be implemented.

Price Negotiations For 10 US Prescription Drugs To Be Shared

Ten high-cost brand-name Part D drugs will be soon announced by the Centers for Medicare & Medicaid Services, U.S. Department of Health and Human Services.